Combination of gallium citrate and levofloxacin induces a distinct metabolome profile and enhances growth inhibition of multidrug-resistant Mycobacterium tuberculosis compared to linezolid
2024

Gallium Citrate and Levofloxacin Combination Fights Drug-Resistant Tuberculosis

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ilchenko Oleksandr, Nikolaevskaya Elena, Zinchenko Oksana, Ivanytsia Volodymyr, Prat-Aymerich Cristina, Ramstedt Madeleine, Rzhepishevska Olena

Primary Institution: UmeƄ University, Sweden

Hypothesis

How does the combination of gallium citrate and levofloxacin affect the growth and metabolome of multidrug-resistant Mycobacterium tuberculosis?

Conclusion

The combination of gallium citrate and levofloxacin significantly enhances growth inhibition of multidrug-resistant Mycobacterium tuberculosis compared to linezolid.

Supporting Evidence

  • The combination of gallium and levofloxacin showed a statistically significant increase in growth inhibition compared to gallium alone.
  • Distinct metabolite profiles were observed when Mtb was treated with gallium in combination with levofloxacin versus linezolid.
  • Gallium treatment increased levels of specific metabolites indicating disruption of iron-dependent metabolic pathways.

Takeaway

This study shows that using gallium citrate with levofloxacin can help fight tough tuberculosis germs better than using linezolid alone.

Methodology

Mtb was cultured using a BACTEC 960 system with varying concentrations of gallium and antibiotics, followed by metabolome analysis using chromatography-mass spectrometry.

Limitations

The study primarily focuses on in vitro results, which may not fully translate to in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fmicb.2024.1474071

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication